Status:
COMPLETED
Nebulized 3% Hypertonic Saline Solution Treatment of Bronchiolitis in Infants
Lead Sponsor:
Coordinación de Investigación en Salud, Mexico
Conditions:
Bronchiolitis
Wheezing
Eligibility:
All Genders
2-24 years
Phase:
PHASE4
Brief Summary
\- Determine the efficacy of nebulized salbutamol/hypertonic saline combination in moderate to severe bronchiolitis.
Detailed Description
* Study design: double-blind, randomized, parallel-controlled prospective study. * Location: Department of pediatric emergencies and pediatric hospitalization of Highly Specialized Medical Unit (HSMU)...
Eligibility Criteria
Inclusion
- All pediatric patients aged 2 months to 24 months of age, both genders attending the pediatric emergency service.
- With first episode of wheezing associated with respiratory distress and a history of upper respiratory tract infection.
- You have the evaluation of respiratory difficulty with Scale Hospital Sant Joan de Deu (HSJD) from 6 to 16 at entry points (moderate and severe degree).
Exclusion
- Subjects with a history of previous wheezing, asthma, or who have received bronchodilator treatment before the present illness.
- Subjects with chronic lung disease, with heart disease, with congenital or acquired anatomic abnormalities of the airway.
Key Trial Info
Start Date :
August 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2017
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT02233985
Start Date
August 1 2013
End Date
March 1 2017
Last Update
June 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unidad Medica de Alta Especialidad Bajío No. 48 Hospital de Gineco - Pediatría. Instituto Mexicano del Seguro Social
León, Guanajuato, Mexico, 37320